Medicine Shortages Webinar: Damian Holly Supply Chain Resilience Overview.

11 December 2020

Policy

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

5 November 2020

Report

Educational material on biosimilar medicines, developed by IGBA (International Generic and Biosimilar Medicines Association)

2 November 2020

External Resource

Positioning Statements on Physician-led Switching for Biosimilar Medicines

1 October 2020

Policy

Positioning statements on physician-led switching for biosimilar medicines (September 2020) […]

Second wave pandemic preparedness: procurement principles

24 August 2020

Policy

Policy Roadmap for Medicines Manufacturing Leadership

6 July 2020

Policy

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

25 June 2020

Policy

COVID-19 “Round 2” – Findings & way forward (Kearney)

22 June 2020

Report

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

22 June 2020

Policy

LESSONS LEARNED FROM COVID-19 – POLICY PAPER

22 June 2020

Policy